Northern Trust’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,157
| Closed | -$205K | – | 4420 |
|
|
2024
Q4 | $205K | Buy |
+5,157
| New | +$205K | ﹤0.01% | 3983 |
|
|
2024
Q3 | – | Sell |
-3,678
| Closed | -$32.2K | – | 4413 |
|
|
2024
Q2 | $32.2K | Sell |
3,678
-3
| -0.1% | -$26 | ﹤0.01% | 4276 |
|
|
2024
Q1 | $90.2K | Buy |
3,681
+1,522
| +70% | +$37.3K | ﹤0.01% | 4105 |
|
|
2023
Q4 | $35.8K | Buy |
2,159
+585
| +37% | +$9.71K | ﹤0.01% | 4292 |
|
|
2023
Q3 | $29.4K | Hold |
1,574
| – | – | ﹤0.01% | 4266 |
|
|
2023
Q2 | $38.2K | Hold |
1,574
| – | – | ﹤0.01% | 4281 |
|
|
2023
Q1 | $34.4K | Buy |
1,574
+270
| +21% | +$5.9K | ﹤0.01% | 4349 |
|
|
2022
Q4 | $31.1K | Hold |
1,304
| – | – | ﹤0.01% | 4394 |
|
|
2022
Q3 | $36K | Hold |
1,304
| – | – | ﹤0.01% | 4410 |
|
|
2022
Q2 | $39K | Sell |
1,304
-6,369
| -83% | -$190K | ﹤0.01% | 4472 |
|
|
2022
Q1 | $412K | Sell |
7,673
-479
| -6% | -$25.7K | ﹤0.01% | 3815 |
|
|
2021
Q4 | $2.42M | Buy |
8,152
+220
| +3% | +$65.3K | ﹤0.01% | 3134 |
|
|
2021
Q3 | $3.08M | Buy |
7,932
+811
| +11% | +$315K | ﹤0.01% | 3045 |
|
|
2021
Q2 | $3.63M | Buy |
7,121
+2,575
| +57% | +$1.31M | ﹤0.01% | 3032 |
|
|
2021
Q1 | $2.58M | Sell |
4,546
-229
| -5% | -$130K | ﹤0.01% | 3114 |
|
|
2020
Q4 | $3.3M | Buy |
+4,775
| New | +$3.3M | ﹤0.01% | 2921 |
|